Clinical Research Facility

Fort Pierce, Florida 34982

Use our guide to learn which trials are right for you!

We've found
11 trials
at this facility
HIV-1 Infection Clinical Trial
Safety and Efficacy of Switching to a FDC of GS-9883/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women
Status: Enrolling, Phase III
Updated: 3/15/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to GS-9883/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to GS-9883/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection
Status: Enrolling, Phase III
Updated: 3/13/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Status: Enrolling, Phase III
Updated: 3/14/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Immunodeficiency Virus Type 1, Human Clinical Trial
A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Human Immunodeficiency Virus Type 1 Clinical Trial
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
A Follow up Study Designed to Obtain Long Term Data on Subjects Who Either Achieved a Sustained Virologic Response or or Did Not Achieve a Sustained Virologic Response in an Abbott Sponsored Hepatitis C Study
Status: Enrolling, Phase III
Updated: 1/13/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Status: Enrolling, Phase II
Updated: 1/18/2016
mi
from
Fort Pierce, FL
Click here to add this to my saved trials